Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS launches new billing system

3/18/24 MTSS

Rusal started using aluminum quotations on the Shanghai Exchange

3/18/24 RUAL

Ministry of Transport proposed to introduce parking lots for electric scooters

3/18/24 WUSH

Nornickel and partners to evaluate Cuba's nickel deposits

3/18/24 GMKN

TRK reported for 2023 by RAS

3/15/24 TORS

Rusal reported for 2023 by RAS

3/15/24 RUAL

EL5-Energo reported for 2023 by RAS

3/15/24 ELFV

Yuzhuralnickel reported for 2023 by RAS

3/15/24 UNKL

On brainbox.VC appeared CyberTsekh

3/15/24 OTCI

Muromteplovoz is transferred to the management of Kamaz

3/15/24 KMAZ